期刊文献+

垂体瘤海绵窦侵袭性与CD34和PTTG表达的关系

Expression of CD34 and PTTG relates to pituitary adenomas with invasion of the cavernous sinus space
下载PDF
导出
摘要 目的:探讨海绵窦侵袭性垂体腺瘤的CD34和垂体瘤转化基因(pituitary tumor transforming gene,PTTG)表达特点。方法:收集62例手术治疗的垂体大腺瘤患者资料,按照Knosp标准对肿瘤进行分组,对标本行CD34和PTTG免疫组化染色检查,对染色结果进行统计学比较。结果:62例患者中海绵窦侵袭二级以上者共23例,微血管密度(MVD)平均值为44.04,PTTG超过(++)为71.4%(15/21),海绵窦侵袭二级和二级以下者共39例,MVD平均值为33.12,PTTG超过(++)为30.6%(11/36),χ2检验两者差异有统计学意义(P<0.05)。结论:海绵窦侵袭超过Ⅱ级的垂体腺瘤其微血管密度大,PTTG表达强度高,肿瘤具有较强的侵袭性,手术全切困难,术后易复发,术后应给予放射治疗或是药物辅助治疗。 Objective: To investigate the characteristics of CD34 and PrIG expression in pituitary adenomas with invasion of Re cavernous sinus space. Methods: Sixty-two patients with large pituitary adenomas were divided into groups based on the Knosp criteria. Expression of CD34 and PTrG was determined by immunohistochemical method. Resuits: The mean microvascular density (MVD) of tumors which surpassed the latemal marginal level of ICA was 44.04, and their PTrG exceeding ( ++ ) ranked 71.4%(15/21). And, the mean MVD of tumors within the latemal marginal level of ICA was 33.12, and the PTIG that exceeding ( + + ) ranked 30.6% (11/36). There were statistical differences between the two groups ( P 〈 0.05). Conclusion: Pituitary adenomas surpassing the latemal marginal level of ICA have strong expression of MVD and P'ITG and strong invasiveness, so they are difficult to remove completely and should be treated with radiotherapy or drugs after surgery.
出处 《山东大学学报(医学版)》 CAS 北大核心 2007年第8期821-824,共4页 Journal of Shandong University:Health Sciences
关键词 垂体肿瘤 海绵窦 侵袭性 免疫组织化学 Pituitary neoplasms Cavemous sinus Invasiveness Immunohistochemistry
  • 相关文献

参考文献8

二级参考文献37

  • 1惠国桢,朱晓江,王之敏,周幽心,胡锦,吴思荣.经蝶窦显微手术治疗垂体巨腺瘤(附54例报告)[J].中华神经外科杂志,1995,11(2):73-75. 被引量:85
  • 2Pei L, Melmed S. Isolation and characterization of a pituitary tumor-transforming gene (PTTG) [J]. Mol Endocrinol, 1997,11 (4) :433-441.
  • 3Dominguez A, Ramos-Morales F, Romero F, et al. Hpttg, a human homologue of rat pttg, is overexpressed in hematopoietic neoplasms. Evidence for a transcriptional activation function of hPTTG[J]. Oncogene, 1998, 17(17):2187-2193.
  • 4Zhang X, Horwitz GA, Prezant TR, et al. Structure, expression, and function of human pituitary tumor-transforming gene(PTTG) [J]. Mol Endocrinol, 1999, 13( 1 ) : 156-166.
  • 5Prezant TR, Kadioglu P, Melmed S. An intronless homolog of human proto-oncogene hPTTG is expressed in pituitary tumors: evidence for hPTG family [J ]. J Clin Endocrinol Metab, 1999, 84(3) : 1149-1152.
  • 6Chen L, Puff R, Lefkowitz EJ, et al. Identification of the human pituitary tumor transforming gene (hPTTG) family: molecular structure, expression, and chromosomal localization[J]. Gene, 2000, 248(1-2):41-50.
  • 7Strausberg RL, Dahl CA, Clausner RD. NEW opportunities for uncovering the molecular basis of cancer [J]. NatGenet,1997.15,415-416.
  • 8Kakar SS. Molecular cloning, genomic organization, and identification of the promoter for the human pituitary tumor transforming gene (PTTG)[J]. Gene, 1999,240(2):317-324.
  • 9Zhang X, Horwitz GA, Heaney AP, et al. Pituitary tumor transforming gene (PTTG) expression in pituitary adenomas[J]. J Clin Endocrinol Metab, 1999, 84(2) :761-767.
  • 10Saez C, Japon MA, Ramos-Morales F, et al. Hpttg is over-expressed in pituitary adenomas and other primary epithelial neoplasias[J]. Oncogene, 1999,18(39):5473-5476.

共引文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部